The central purpose of this investigation was to determine if either the AT8 or PHF1 phospho-tau epitopes, when displayed on Qβ VLPs, would be efficacious in generating targeted antibody responses, reducing tau pathology, and rescuing cognitive deficits in the rTg4510 model of tauopathy. The gene discussed is PHF1; the disease is Cognitive impairment.